

Delivering on a promise is a tough proposition, and to consistently deliver requires excellence on all fronts.
You can purchase shares of Cerus (NASDAQ:CERS) through any online brokerage.
Other companies in Cerus’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
Cerus has a consensus price target of $4.17.
The stock price for Cerus (NASDAQ: CERS) is $2.33 last updated October 23, 2026 at 4:37 PM EDT.
There are no upcoming dividends for Cerus.
Cerus does not have any upcoming earnings scheduled.
There is no upcoming split for Cerus.
Cerus is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses,...